Association of Neonatal Hypoglycemia With Academic Performance in Mid-Childhood

Rajesh Shah1, Darren W T Dai1, Jane M Alsweiler2

  • 1Liggins Institute, University of Auckland, Auckland, New Zealand.

JAMA
|March 22, 2022
PubMed

Insights

Neonatal hypoglycemia did not significantly impact overall educational achievement in children. However, treated infants showed better reading performance compared to those not exposed to hypoglycemia.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Educational Psychology

Background:

  • Neonatal hypoglycemia is linked to potential deficits in executive and visual-motor functions.
  • The long-term educational implications of neonatal hypoglycemia remain unclear.
  • Early identification and management of neonatal hypoglycemia are crucial.

Purpose of the Study:

  • To investigate the association between neonatal hypoglycemia and educational performance at 9–10 years of age.
  • To determine if exposure to neonatal hypoglycemia affects academic achievement in mid-childhood.
  • To evaluate the relationship between treated neonatal hypoglycemia and later learning outcomes.

Main Methods:

  • A prospective cohort study involving infants at risk of hypoglycemia.
  • Continuous glucose monitoring (blood and interstitial) was used for up to 7 days.
  • Educational performance was assessed at 9–10 years using standardized tests in reading and mathematics.

Main Results:

  • No significant difference in overall low educational achievement between exposed and unexposed groups.
  • Children exposed to neonatal hypoglycemia were less likely to perform below curriculum level in reading.
  • No significant differences were observed for other secondary outcomes, including executive function and psychosocial adaptation.

Conclusions:

  • Screening and treatment of neonatal hypoglycemia did not lead to significantly lower educational achievement in mid-childhood.
  • Early intervention for neonatal hypoglycemia may be associated with improved reading performance.
  • Further research is needed to understand the nuanced effects of neonatal hypoglycemia on long-term development.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
363
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
403
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
292
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K